How severe is CVE-2020-16198?

CVE-2020-16198 has a CVSS 3.x base score of 5.0, rated medium severity. It is exploitable over an adjacent network with high attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability low.

Is CVE-2020-16198 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (45th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2020-16198?

CVE-2020-16198 affects Philips Clinical Collaboration Platform. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2020-16198?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2020-16198 published?

CVE-2020-16198 was published on 2020-09-18 and last updated on 2026-06-17.

CVE-2020-16198

CVE-2020-16198 is a medium-severity vulnerability in Philips Clinical Collaboration Platform with a CVSS 3.x base score of 5.0. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-693.

Key facts

Severity: Medium (CVSS 3.x base score 5.0)
CVSS v2: 5.8
EPSS exploit prediction: 1% (45th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-693
Affected product: Philips Clinical Collaboration Platform
Published: 2020-09-18
Last modified: 2026-06-17

Description

When an attacker claims to have a given identity, Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not prove or insufficiently proves the claim is correct.

Frequently asked questions

What is CVE-2020-16198?: When an attacker claims to have a given identity, Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not prove or insufficiently proves the claim is correct.
How severe is CVE-2020-16198?: CVE-2020-16198 has a CVSS 3.x base score of 5.0, rated medium severity. It is exploitable over an adjacent network with high attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability low.
Is CVE-2020-16198 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (45th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-16198?: CVE-2020-16198 affects Philips Clinical Collaboration Platform. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2020-16198?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2020-16198 published?: CVE-2020-16198 was published on 2020-09-18 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:philips:clinical_collaboration_platform:*:*:*:*:*:*:*:*

More vulnerabilities in Philips Clinical Collaboration Platform

CVE-2020-16247 — Medium (CVSS 6.8): Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, exposes a resource to the wrong control sphere,…
CVE-2025-27955 — Medium (CVSS 6.5): Clinical Collaboration Platform 12.2.1.5 has a weak logout system where the session token remains valid after logout…
CVE-2025-27954 — Medium (CVSS 6.5): An issue in Clinical Collaboration Platform 12.2.1.5 allows a remote attacker to obtain sensitive information and…
CVE-2025-27953 — Medium (CVSS 6.5): An issue in Clinical Collaboration Platform 12.2.1.5 allows a remote attacker to obtain sensitive information and…
CVE-2020-16200 — Medium (CVSS 6.5): Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not properly control the allocation and…
CVE-2020-14525 — Low (CVSS 3.5): Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes…

All CVEs affecting Philips Clinical Collaboration Platform →

Other CWE-693 (Protection Mechanism Failure) vulnerabilities

CVE-2026-93606 — Critical (CVSS 10.0): vm2 (npm) versions 3.12.0 and earlier contain a sandbox escape in `VM` and `NodeVM`. When an embedder exposes a host…
CVE-2026-93605 — Critical (CVSS 10.0): vm2 NodeVM versions before 3.12.1 contain a sandbox escape vulnerability where the DANGEROUS_BUILTINS denylist omits…
CVE-2026-92956 — Critical (CVSS 10.0): vm2 versions 3.10.1 through 3.11.6 contain a sandbox escape reachable from a default `new VM()` sandbox when running on…
CVE-2026-75874 — Critical (CVSS 10.0): Sandbox escape in the Remote Settings Client component. This vulnerability was fixed in Firefox 154, Thunderbird 154,…
CVE-2026-47140 — Critical (CVSS 10.0): vm2 is an open source vm/sandbox for Node.js. Prior to version 3.11.4, NodeVM blocks several dangerous Node.js builtins…
CVE-2026-34208 — Critical (CVSS 10.0): SandboxJS is a JavaScript sandboxing library. Prior to 0.8.36, SandboxJS blocks direct assignment to global objects…

Browse all CWE-693 (Protection Mechanism Failure) vulnerabilities →